Breast cancer, affecting primarily women, is one of the most common cancers with increasing survival rates, yet treatment remains an area for improvement.1 As of 2019, female breast cancer has the highest rates of new diagnoses and is the second highest in number of cancer-related deaths in ...
Although large-scale studies are still needed to confirm their effectiveness, the newest FDA-approved treatments for fibromyalgia include Quell and milnacipran. Quell is an over-the-counter transcutaneous electrical nerve stimulator intended to be used for pain relief. Milnacipran is a serotonin and ...
"I'm happy that my team's research is starting to shed light on what might be causing cognitive problems in patients with cancer," Janelsins said, "and I'm hopeful that we'll be able to come up with treatments in the future." AnnaLynn M. Williams et al. Associations between inflammat...
Public perception of propylparaben safety is clouded by the results of a controversial 2004 study that connected parabens and breast cancer. Philippa Darbre, professor emeritus in the School of Biological Sciences at the University of Reading in Great Britain, who led the study, maintains t...